ISSN:

Journal Home

Translational Neurodegeneration Q1 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Translational Neurodegeneration is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 62. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on neurodegenerative diseases, dementia, motor neurone disease, Parkinson's disease, Alzheimer's disease. It has an SJR impact factor of 3,371 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,371.

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cellular and Molecular Neuroscience (Q1) Cognitive Neuroscience (Q1) Neurology (clinical) (Q1)

Price

2390 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,371

SJR Impact factor

62

H Index

56

Total Docs (Last Year)

146

Total Docs (3 years)

6597

Total Refs

1800

Total Cites (3 years)

140

Citable Docs (3 years)

9.63

Cites/Doc (2 years)

117.8

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1

Compare this journals

Aims and Scope

Neurodegenerative diseases Dementia Motor neurone disease Parkinson's disease Alzheimer's disease